0001493152-20-016100.txt : 20200817 0001493152-20-016100.hdr.sgml : 20200817 20200817163032 ACCESSION NUMBER: 0001493152-20-016100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karkus Ted William CENTRAL INDEX KEY: 0001457896 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 201110571 MAIL ADDRESS: STREET 1: 188 HEWLETT NECK ROAD CITY: WOODMERE STATE: NY ZIP: 11598 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2020-08-13 0 0000868278 ProPhase Labs, Inc. PRPH 0001457896 Karkus Ted William 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 1 1 0 CEO & CHAIRMAN Common Stock, par value $0.005 2020-08-13 4 S 0 50000 2.75 D 2419528 D Common Stock, par value $0.005 40000 I By Son Common Stock, par value $0.005 40000 I By Son These shares were sold in a private transaction to Louis Gleckel, a director of the Issuer, pursuant to the terms of a Stock Purchase Agreement. /s/ Ted Karkus 2020-08-17